Carmat TAH Early Feasibility Study
NCT04117295 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2025-01-28
Summary
Feasibility study of the Carmat TAH as a treatment for transplant-eligible patients in severe, end-stage heart failure.
Conditions
- End-stage Heart Failure
Interventions
- DEVICE
-
Carmat Total Artificial Heart
Heart replacement therapy
Sponsors & Collaborators
-
Carmat SA
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-07-12
- Primary Completion
- 2026-04-30
- Completion
- 2027-01-31
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Early Feasibility Study of the Cardiovalve System for Tricuspid Regurgitation
NCT04100720 ·Status: WITHDRAWN ·Phase: NA
-
Feasibility Study of Patients With Severe MR Treated With the Cardiovalve TMVR System
NCT03714412 ·Status: WITHDRAWN ·Phase: NA
-
LVAD in Non Cardiac Transplant Candidates and Non Responders to Resynchronization
NCT01126944 ·Status: WITHDRAWN ·Phase: NA
-
PARACHUTE V PercutAneous Ventricular RestorAtion in Chronic Heart FailUre Due to Ischemic HearT DiseasE.
NCT02543632 ·Status: TERMINATED
-
Clinical Trial to Evaluate the the ReliantHeart HeartAssist 5® VAD System in Patients Awaiting Heart Transplantation
NCT02205411 ·Status: TERMINATED ·Phase: NA
-
Left Ventricular Assist Device Combined With Allogeneic Mesenchymal Stem Cells Implantation in Patients With End-stage Heart Failure.
NCT01759212 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
EFS of the CardioMech MVRS
NCT04820764 ·Status: RECRUITING ·Phase: NA
-
ImCardia for DHF to Treat Diastolic Heart Failure (DHF) Patient a Pilot Study
NCT01347125 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Early Versus Emergency Left Ventricular Assist Device Implantation in Patients Awaiting Cardiac Transplantation
NCT02387112 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Early Feasibility Study of the CardiAQ™ TMVI System (Transfemoral and Transapical DS)
NCT02515539 ·Status: WITHDRAWN ·Phase: NA
-
Effect of HCO1100 on Cardiovascular Function
NCT01363921 ·Status: TERMINATED ·Phase: NA
-
Transmural Systems Transcaval Closure Device for Transcaval Access Ports During Transcatheter Aortic Valve Replacement
NCT03432494 ·Status: TERMINATED ·Phase: NA
-
SynCardia 70cc TAH-t for Destination Therapy (DT)
NCT02232659 ·Status: UNKNOWN ·Phase: NA
-
Registry for Cardiogenic Shock: Utility and Efficacy of Device Therapy
NCT02790242 ·Status: TERMINATED
-
Study of Safety and Efficacy of the Percutaneous Reduction of Mitral Valve Regurgitation in Heart Failure Patients
NCT00787293 ·Status: SUSPENDED ·Phase: PHASE2
-
A Pivotal Trial to Establish the Efficacy and Long-term Safety of the Parachute Implant System
NCT01614652 ·Status: TERMINATED ·Phase: PHASE3
-
Observational Study of the Heart Repair Technologies Mitral Bridge in Treating Mitral Valve Regurgitation
NCT03511716 ·Status: TERMINATED
-
ATS 3f(r) Aortic Bioprosthesis Model 1000 Post Approval Study
NCT01116037 ·Status: TERMINATED ·Phase: NA
-
Early Feasibility Study for the Foldax TRIA Mitral Heart Valve Replacement
NCT04717570 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Transfemoral Replacement of Aortic Valve With HLT MeriDIAN Valve Early Feasibility Trial
NCT02799823 ·Status: TERMINATED ·Phase: NA
-
Evaluation of the HeartWare Left Ventricular Assist Device for the Treatment of Advanced Heart Failure
NCT00751972 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement
NCT01240902 ·Status: COMPLETED ·Phase: NA
-
DAA Treatment in Donor HCV-positive to Recipient HCV-negative Heart Transplant
NCT03208244 ·Status: TERMINATED ·Phase: PHASE4
-
Safety and Performance Study of the Harpoon Mitral Valve Repair System
NCT03285724 ·Status: TERMINATED ·Phase: NA
-
An Automated Continual Water Removal System in Patients With Advanced Diuretic Resistant Heart Failure
NCT05140759 ·Status: TERMINATED ·Phase: NA